Structural basis for C-type inactivation in a Shaker family voltage-gated K+ channel. 2022

Ravikumar Reddi, and Kimberly Matulef, and Erika A Riederer, and Matthew R Whorton, and Francis I Valiyaveetil
Program in Chemical Biology, Department of Chemical Physiology and Biochemistry, Oregon Health & Science University, 3181 SW Sam Jackson Park Rd, Portland, OR 97239, USA.

C-type inactivation is a process by which ion flux through a voltage-gated K+ (Kv) channel is regulated at the selectivity filter. While prior studies have indicated that C-type inactivation involves structural changes at the selectivity filter, the nature of the changes has not been resolved. Here, we report the crystal structure of the Kv1.2 channel in a C-type inactivated state. The structure shows that C-type inactivation involves changes in the selectivity filter that disrupt the outer two ion binding sites in the filter. The changes at the selectivity filter propagate to the extracellular mouth and the turret regions of the channel pore. The structural changes observed are consistent with the functional hallmarks of C-type inactivation. This study highlights the intricate interplay between K+ occupancy at the ion binding sites and the interactions of the selectivity filter in determining the balance between the conductive and the inactivated conformations of the filter.

UI MeSH Term Description Entries

Related Publications

Ravikumar Reddi, and Kimberly Matulef, and Erika A Riederer, and Matthew R Whorton, and Francis I Valiyaveetil
September 1992, Trends in pharmacological sciences,
Ravikumar Reddi, and Kimberly Matulef, and Erika A Riederer, and Matthew R Whorton, and Francis I Valiyaveetil
June 2001, Biophysical journal,
Ravikumar Reddi, and Kimberly Matulef, and Erika A Riederer, and Matthew R Whorton, and Francis I Valiyaveetil
September 1995, Biophysical journal,
Ravikumar Reddi, and Kimberly Matulef, and Erika A Riederer, and Matthew R Whorton, and Francis I Valiyaveetil
February 2000, The Journal of general physiology,
Ravikumar Reddi, and Kimberly Matulef, and Erika A Riederer, and Matthew R Whorton, and Francis I Valiyaveetil
February 2012, Pharmacology & therapeutics,
Ravikumar Reddi, and Kimberly Matulef, and Erika A Riederer, and Matthew R Whorton, and Francis I Valiyaveetil
September 2008, Biophysical journal,
Ravikumar Reddi, and Kimberly Matulef, and Erika A Riederer, and Matthew R Whorton, and Francis I Valiyaveetil
October 2006, Progress in biophysics and molecular biology,
Ravikumar Reddi, and Kimberly Matulef, and Erika A Riederer, and Matthew R Whorton, and Francis I Valiyaveetil
January 1996, Neuropharmacology,
Ravikumar Reddi, and Kimberly Matulef, and Erika A Riederer, and Matthew R Whorton, and Francis I Valiyaveetil
March 2013, European journal of pharmacology,
Ravikumar Reddi, and Kimberly Matulef, and Erika A Riederer, and Matthew R Whorton, and Francis I Valiyaveetil
August 2005, Science (New York, N.Y.),
Copied contents to your clipboard!